Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 14846-62-9
2. Chembl43326
3. G484l3u0o2
4. Nsc321803
5. Nsc-321803
6. Estra-1,3,5(10)-trien-17-one, 3-methoxy-4-nitro-
7. 3-methoxy-4-nitro-estra-1,3,5(10)-trien-17-one
8. Nsc 321803
9. (8r,9s,13s,14s)-3-methoxy-13-methyl-4-nitro-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-one
10. Unii-g484l3u0o2
11. Schembl9362693
12. Dtxsid90163991
13. Zinc3780812
14. Bdbm50028411
15. Nci-321803
16. Nci60_002792
17. 3-methoxy-4-nitro-1,3,5(10)-estratrien-17-one
18. Estra-1,5[10]-trien-17-one, 3-methoxy-4-nitro-
19. Q27896339
20. 3-methoxy-13-methyl-4-nitro-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one
| Molecular Weight | 329.4 g/mol |
|---|---|
| Molecular Formula | C19H23NO4 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 329.16270821 g/mol |
| Monoisotopic Mass | 329.16270821 g/mol |
| Topological Polar Surface Area | 72.1 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 4-Nitroestrone 3-Methyl Ether manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4-Nitroestrone 3-Methyl Ether, including repackagers and relabelers. The FDA regulates 4-Nitroestrone 3-Methyl Ether manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4-Nitroestrone 3-Methyl Ether API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 4-Nitroestrone 3-Methyl Ether supplier is an individual or a company that provides 4-Nitroestrone 3-Methyl Ether active pharmaceutical ingredient (API) or 4-Nitroestrone 3-Methyl Ether finished formulations upon request. The 4-Nitroestrone 3-Methyl Ether suppliers may include 4-Nitroestrone 3-Methyl Ether API manufacturers, exporters, distributors and traders.
click here to find a list of 4-Nitroestrone 3-Methyl Ether suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 4-Nitroestrone 3-Methyl Ether DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-Nitroestrone 3-Methyl Ether active pharmaceutical ingredient (API) in detail. Different forms of 4-Nitroestrone 3-Methyl Ether DMFs exist exist since differing nations have different regulations, such as 4-Nitroestrone 3-Methyl Ether USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-Nitroestrone 3-Methyl Ether DMF submitted to regulatory agencies in the US is known as a USDMF. 4-Nitroestrone 3-Methyl Ether USDMF includes data on 4-Nitroestrone 3-Methyl Ether's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-Nitroestrone 3-Methyl Ether USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-Nitroestrone 3-Methyl Ether suppliers with USDMF on PharmaCompass.
4-Nitroestrone 3-Methyl Ether Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4-Nitroestrone 3-Methyl Ether GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4-Nitroestrone 3-Methyl Ether GMP manufacturer or 4-Nitroestrone 3-Methyl Ether GMP API supplier for your needs.
A 4-Nitroestrone 3-Methyl Ether CoA (Certificate of Analysis) is a formal document that attests to 4-Nitroestrone 3-Methyl Ether's compliance with 4-Nitroestrone 3-Methyl Ether specifications and serves as a tool for batch-level quality control.
4-Nitroestrone 3-Methyl Ether CoA mostly includes findings from lab analyses of a specific batch. For each 4-Nitroestrone 3-Methyl Ether CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4-Nitroestrone 3-Methyl Ether may be tested according to a variety of international standards, such as European Pharmacopoeia (4-Nitroestrone 3-Methyl Ether EP), 4-Nitroestrone 3-Methyl Ether JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4-Nitroestrone 3-Methyl Ether USP).
LOOKING FOR A SUPPLIER?
